David Urech

Vorstandsvorsitzender bei Numab Therapeutics AG

Commercial Services

Consumer Services

Profil

David Urech is the founder and currently holds the position of CEO, Director & Chief Scientific Officer at Numab Therapeutics AG, a company he founded in 2011.
He previously held the position of Director-Research & Development at ESBATech AG.
Dr. Urech has a doctorate degree from the University of Basel and an undergraduate degree from the University of Zurich.

Aktive Positionen von David Urech

Unternehmen	Position	Beginn
Numab Therapeutics AG Numab Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland.	Vorstandsvorsitzender	01.01.2011

Alle aktiven Positionen von David Urech

Ehemalige bekannte Positionen von David Urech

Unternehmen	Position	Ende
ESBATech, a Novartis Co. GmbH ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland.	Technik-/Wissenschafts-/F&E-Leiter	-

Sehen Sie sich die Erfahrung von David Urech im Detail an

Ausbildung von David Urech

University of Zurich	Undergraduate Degree
University of Basel	Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von David Urech im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
ESBATech, a Novartis Co. GmbH ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland.	Commercial Services
Numab Therapeutics AG Numab Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland.	Commercial Services